The Bruton's tyrosine kinase inhibitor ibrutinib exerts immunomodulatory effects through regulation of tumor-infiltrating macrophages

The Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has demonstrated promising efficacy in a variety of hematologic malignancies. However, the precise mechanism of action of the drug remains to be fully elucidated. Tumor-infiltrating macrophages presented in the tumor microenvironment have b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ping, Lingyan, Ding, Ning, Shi, Yunfei, Feng, Lixia, Li, Jiao, Liu, Yalu, Lin, Yufu, Shi, Cunzhen, Wang, Xing, Pan, Zhengying, Song, Yuqin, Zhu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503608/
https://www.ncbi.nlm.nih.gov/pubmed/28424405
http://dx.doi.org/10.18632/oncotarget.16836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503608/
https://www.ncbi.nlm.nih.gov/pubmed/28424405
http://dx.doi.org/10.18632/oncotarget.16836

Ejemplares similares